Classical immunomodulatory therapy in multiple sclerosis: how it acts, how it works.
about
Impact of Exercise on Innate Immunity in Multiple Sclerosis Progression and SymptomatologyReassessment of blood gene expression markers for the prognosis of relapsing-remitting multiple sclerosisCognitive dysfunction in multiple sclerosis.Expression and activation by Epstein Barr virus of human endogenous retroviruses-W in blood cells and astrocytes: inference for multiple sclerosis.Relapsing-remitting multiple sclerosis: patterns of response to disease-modifying therapies and associated factors: a national survey.Exercise in multiple sclerosis -- an integral component of disease management.Expert recommendations to personalization of medical approaches in treatment of multiple sclerosis: an overview of family planning and pregnancyElevated type I interferon-like activity in a subset of multiple sclerosis patients: molecular basis and clinical relevance.Switching and escalating therapy in long-lasting multiple sclerosis: not always necessary.Exercise therapy and multiple sclerosis: a systematic review.Glatiramer acetate ameliorates experimental autoimmune neuritis.Astrocyte-derived retinoic acid: a novel regulator of blood-brain barrier function in multiple sclerosis.Interferon-beta therapy in multiple sclerosis: the short-term and long-term effects on the patients' individual gene expression in peripheral blood.Comparative pharmacogenetics of multiple sclerosis: IFN-β versus glatiramer acetate.
P2860
Q26745562-2C94EA21-3614-441A-BA72-E5ABE609412EQ28740839-4C86F177-E3DA-491A-B297-6E03BF2E006AQ34288839-9FF89A3A-A044-4799-951D-77B9E40C5D39Q34427836-86D8CE77-481C-47BA-83E2-A50915081ED7Q35280670-504EC731-E9BD-4A58-9895-4378E987BB73Q36031826-306FEEDA-8E94-418F-BEC2-EBF49C9153A8Q36298897-AA521E15-B970-463B-B151-1903C1E79A96Q36298955-AF554003-70BB-4A57-AE6E-B35240CAD1AEQ36515730-63E16F0E-90C3-4CFA-968A-0AA94B251EF4Q38165020-C7331D18-0BEC-412B-90FA-C330E0D20D82Q43986497-657D0C64-4488-4715-83A0-B1454C5DD310Q46848816-AEFAF09B-5083-4BDE-B1F3-2B0833C19BD8Q51025796-D81AE8B4-FCD0-4DA1-9834-F3107CA61368Q51089837-B7AD6313-4190-41C8-B724-C1825590723A
P2860
Classical immunomodulatory therapy in multiple sclerosis: how it acts, how it works.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Classical immunomodulatory therapy in multiple sclerosis: how it acts, how it works.
@ast
Classical immunomodulatory therapy in multiple sclerosis: how it acts, how it works.
@en
type
label
Classical immunomodulatory therapy in multiple sclerosis: how it acts, how it works.
@ast
Classical immunomodulatory therapy in multiple sclerosis: how it acts, how it works.
@en
prefLabel
Classical immunomodulatory therapy in multiple sclerosis: how it acts, how it works.
@ast
Classical immunomodulatory therapy in multiple sclerosis: how it acts, how it works.
@en
P2860
P1476
Classical immunomodulatory therapy in multiple sclerosis: how it acts, how it works.
@en
P2093
Amélia Mendes
Maria José Sá
P2860
P304
P356
10.1590/S0004-282X2011000400024
P577
2011-06-01T00:00:00Z